Oncolytic parvoviruses: from basic virology to clinical applications - Wikidata - wikimedia - TriplyDB

Oncolytic parvoviruses: from basic virology to clinical applications

Oncolytic parvoviruses: from basic virology to clinical applications

http://www.wikidata.org/entity/Q28081685

about

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade Fighting Cancer with Mathematics and Viruses.The SAT Protein of Porcine Parvovirus Accelerates Viral Spreading through Induction of Irreversible Endoplasmic Reticulum Stress.Virotherapy of digestive tumors with rodent parvovirus: overview and perspectives.Protoparvovirus Knocking at the Nuclear Door.Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction.Protoparvovirus Cell Entry.Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity.Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro.Designing and building oncolytic viruses.Viral highway to nucleus exposed by image correlation analyses.White paper on microbial anti-cancer therapy and prevention Possible risks posed by single-stranded DNA viruses of pigs associated with xenotransplantation Association of the Human Bocavirus With Tonsil Squamous Cell Carcinomas Endogenous amdoparvovirus-related elements reveal insights into the biology and evolution of vertebrate parvoviruses

P2860

Q26769977-427884A4-3930-4506-AE3A-5E720A5350AB Q38612646-856EF0A0-BC46-4E79-BC49-89BAC9E063CB Q38701700-F438FDC4-C051-4F15-8171-F7C282A2BC16 Q38726011-7927A77D-3003-49E2-997F-73A57B0B0AAF Q41925259-9750AA54-79F7-4148-8865-0F6CFCEF6930 Q46210737-CF7D0B12-9838-45B5-BD66-34B67C970C6F Q46274294-DA36D614-F96D-4D74-B7B4-689A0BFFD150 Q47100447-9A88C266-0A58-495F-8F8B-F75835DDABDB Q47242457-737CCBB3-D7BD-464E-9372-6FFFD86B353E Q47547386-E3FEDDAC-2F43-443F-9DD5-24AC1F4738BF Q47551667-475FF218-20F9-4796-8FCF-CBE295C2B451 Q56898750-465ACB1C-1F08-464C-9315-0A01C01887D8 Q56997423-17E229D7-01DF-429C-80BA-C2835A47A387 Q59127923-E2DA993F-8609-46F2-94F8-DE6B33A897C3 Q59132690-7DF2E770-3B69-459F-B8E6-532FA43B06DD

P2860

Oncolytic parvoviruses: from basic virology to clinical applications

http://www.wikidata.org/entity/Q28081685

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Oncolytic parvoviruses: from basic virology to clinical applications

@ast

Oncolytic parvoviruses: from basic virology to clinical applications

@en

Oncolytic parvoviruses: from basic virology to clinical applications

@nl

type

label

Oncolytic parvoviruses: from basic virology to clinical applications

@ast

Oncolytic parvoviruses: from basic virology to clinical applications

@en

Oncolytic parvoviruses: from basic virology to clinical applications

@nl

prefLabel

Oncolytic parvoviruses: from basic virology to clinical applications

@ast

Oncolytic parvoviruses: from basic virology to clinical applications

@en

Oncolytic parvoviruses: from basic virology to clinical applications

@nl

P1433

Q28081685-78E3F0F1-472B-477A-B594-75A324066787

P1476

Q28081685-A22E1822-CC1A-442D-865E-A94111086D5E

P2093

Q28081685-682CC741-36C2-419E-856C-44CEAB6991AB

Q28081685-9B4BD26A-7416-4F9B-9267-B24C86F16EFF

Q28081685-BBA89BC4-DA55-41B6-AA90-45895373ACFB

Q28081685-F563682C-F53F-4E7C-BA93-013AF8AC1ECB

P275

Q28081685-F496C415-EC2E-4F9A-BD5B-F4A56A765484

P2860

Q28081685-01695898-FACF-4281-829F-5E6A5E1FF34A

Q28081685-03B3A6E5-46AB-407F-BA61-F9998D34DE48

Q28081685-044C2FE2-F400-4A3B-B4AF-9DDC376A35B0

Q28081685-04B628AA-EE4E-4F80-8B35-7FE58DB0E713

Q28081685-056D3831-E328-4B18-8182-D165A6DCDC48

Q28081685-059A6994-1941-4450-B490-09F4BCF0C8D3

Q28081685-0718402A-941E-4464-9353-F5E50E958935

Q28081685-0F206229-7693-4269-977E-B4F87DBB6B42

Q28081685-1398B66A-5F39-47B9-95D2-3639BCAE5D74

Q28081685-1899C7C3-D756-4CF5-9461-757AE85CCBE3

P2888

Q28081685-477048FC-BD06-427A-BCCA-3E23B56E0A1E

P304

Q28081685-4A213C63-52B8-415B-920A-4BB5E05E2456

P31

Q28081685-C65530F6-82C7-4924-A46D-B782ACCEBF7B

P356

Q28081685-08612834-C728-438C-BDE5-16362C175BCC

P407

Q28081685-CC0101A4-3C59-418C-A083-251372D55A08

P478

Q28081685-6AC639DE-2548-4484-8902-418ADED599BE

P50

Q28081685-4B0D7B08-EB34-48D3-8933-72B012A61D5D

P5008

Q28081685-BEA21D12-1374-4059-AB7A-95CFDCFF93AB

P577

Q28081685-8040B7BC-1292-48B7-A343-E6C9F4904DBC

P5875

Q28081685-6AEE568D-47AC-4791-968C-5A84A53978AE

P6179

Q28081685-9CB0DD0D-E1F4-48A4-AEDD-9DD58CE97167

P698

Q28081685-594C3612-E565-478E-8016-7522B50D7640

P921

Q28081685-9F311038-28DB-48F8-96DD-312A6BC6419F

Q28081685-BEC685E5-6ED3-49FB-8AC3-664551E9E8CA

Q28081685-C85F68DA-9812-4E9B-9B2C-A7205BBBEA86

Q28081685-D3E9756F-813E-43F4-97D0-EA0FB67BF1CA

Q28081685-E9F77D8F-4D51-4959-943A-F5E24583B660

P932

Q28081685-1E7A8649-4C20-4004-91EA-91751FA08513

P356

S12985-014-0223-Y

P1433

Virology Journal

P1476

Oncolytic parvoviruses: from basic virology to clinical applications

@en

P2093

Assia L Angelova

http://www.w3.org/2001/XMLSchema#string

Eleanor M Scott

http://www.w3.org/2001/XMLSchema#string

Jean Rommelaere

http://www.w3.org/2001/XMLSchema#string

Serena Bonifati

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Parvovirus minute virus of mice induces a DNA damage response that facilitates viral replication

Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells

New viruses for cancer therapy: meeting clinical needs

Patient-derived tumor xenografts: transforming clinical samples into mouse models

Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment

Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis

Structural Characterization of H-1 Parvovirus: Comparison of Infectious Virions to Empty Capsids

Efficient parvovirus replication requires CRL4Cdt2-targeted depletion of p21 to prevent its inhibitory interaction with PCNA

Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system.

The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.

P2888

s12985-014-0223-y

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12985-014-0223-Y

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Marchini

P5008

P577

2015-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271597110

http://www.w3.org/2001/XMLSchema#string

P6179

1026786968

http://www.w3.org/2001/XMLSchema#string

P698

25630937

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

4323056

http://www.w3.org/2001/XMLSchema#string